Stefan Schreiber

1991–2025 年に発表

527
論文数
138,830
被引用数
188
h 指数
503
i10 指数

被引用数

Stefan Schreiber の年別被引用数1971 年: 被引用 1 件1972 年: 被引用 1 件1985 年: 被引用 1 件1987 年: 被引用 1 件1991 年: 被引用 9 件1992 年: 被引用 3 件1993 年: 被引用 9 件1994 年: 被引用 5 件1995 年: 被引用 19 件1996 年: 被引用 20 件1997 年: 被引用 48 件1998 年: 被引用 66 件1999 年: 被引用 90 件2000 年: 被引用 111 件2001 年: 被引用 106 件2002 年: 被引用 206 件2003 年: 被引用 315 件2004 年: 被引用 360 件2005 年: 被引用 450 件2006 年: 被引用 500 件2007 年: 被引用 642 件2008 年: 被引用 764 件2009 年: 被引用 1,104 件2010 年: 被引用 1,326 件2011 年: 被引用 1,622 件2012 年: 被引用 1,502 件2013 年: 被引用 1,796 件2014 年: 被引用 1,938 件2015 年: 被引用 1,850 件2016 年: 被引用 1,620 件2017 年: 被引用 1,768 件2018 年: 被引用 1,637 件2019 年: 被引用 4,222 件2020 年: 被引用 4,421 件2021 年: 被引用 4,424 件2022 年: 被引用 3,714 件2023 年: 被引用 2,992 件2024 年: 被引用 4,063 件2025 年: 被引用 2,049 件2026 年: 被引用 80 件1973〜1984 年は被引用が無いため表示していません1986 年は被引用が無いため表示していません1988〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 13,643 件、この内訳の 21.7%イギリス: 引用元論文 5,081 件、この内訳の 8.1%中国: 引用元論文 4,822 件、この内訳の 7.7%ドイツ: 引用元論文 4,678 件、この内訳の 7.4%イタリア: 引用元論文 2,925 件、この内訳の 4.6%カナダ: 引用元論文 2,778 件、この内訳の 4.4%フランス: 引用元論文 2,552 件、この内訳の 4.1%オランダ: 引用元論文 2,255 件、この内訳の 3.6%オーストラリア: 引用元論文 1,776 件、この内訳の 2.8%スペイン: 引用元論文 1,698 件、この内訳の 2.7%日本: 引用元論文 1,573 件、この内訳の 2.5%スイス: 引用元論文 1,354 件、この内訳の 2.1%
0%21.7%その他 28.3%

分野

  • Biochemistry, Genetics and Molecular Biology46.9%
  • Medicine34.2%
  • Immunology and Microbiology8.8%
  • Neuroscience3.5%
  • Computer Science1.3%
  • Agricultural and Biological Sciences1.3%
  • その他4%

トピック

  • Inflammatory Bowel Disease7%
  • Gut microbiota and health4.7%
  • Genetic Associations and Epidemiology2.3%
  • Microscopic Colitis2.2%
  • Clostridium difficile and Clostridium perfringens research1.5%
  • Rheumatoid Arthritis Research and Therapies1.3%
  • その他81%

共著者

全論文

検索で開く
  1. Swarm Learning for decentralized and confidential clinical machine learning

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena De Domenico, Christian Siever, Michael Kraut, Milind Y. Desai, Bruno Monnet, Maria Saridaki, Charles Siegel, Anna Drews, Melanie Nuesch-Germano, Heidi Theis, Jan Heyckendorf, Stefan Schreiber, Sarah Kim-Hellmuth, COVID-19 Aachen Study (COVAS), Paul Balfanz, Thomas Eggermann, Peter Boor, Ralf Hausmann, Hannah Kuhn, Susanne Isfort, Julia Stingl, Günther Schmalzing, Christiane Kühl, Rainer Röhrig, Gernot Marx, Stefan Uhlig, Edgar Dahl, Dirk Müller‐Wieland, Michael Dreher, Nikolaus Marx, Jacob Nattermann, Dirk Skowasch, Ingo Kurth, Andreas Keller, Robert Bals, Peter Nürnberg, Olaf Rieß, Philip Rosenstiel, Mihai G. Netea, Fabian J. Theis, Sach Mukherjee, Michael Backes, Anna C. Aschenbrenner, Thomas Ulas, Deutsche COVID-19 Omics Initiative (DeCOI), Angel Angelov, Alexander Bartholomäus, Anke Becker, Daniela Bezdan, Conny Blumert, Ezio Bonifacio, Peer Bork, Boyke Bunk, Helmut Blum, Thomas Clavel, Maria Colomé‐Tatché, Markus Cornberg, Inti Alberto De La Rosa Velázquez, Andreas Diefenbach, Alexander Dilthey, Nicole Fischer, Konrad U. Förstner, Sören Franzenburg, Julia-Stefanie Frick, Gisela Gabernet, Julien Gagneur, Tina Ganzenmueller, Marie Gauder, Janina Geißert, Alexander Goesmann ほか 81 名 - Nature 2021 被引用: 880

  2. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabrielle Boucher, Stephan Brand, Carsten Büning, Ariella Cohain, Sven Cichon, Mauro D’Amato, Dirk de Jong, Kathy L. Devaney, Marla C. Dubinsky, Cathryn Edwards, David Ellinghaus, Lynnette Ferguson, Denis Franchimont, Karin Fransén, Richard B. Gearry, Michel Georges, Christian Gieger, Jürgen Glas, Talin Haritunians, Ailsa Hart, Chris Hawkey, Matija Hedl, Xinli Hu, Tom H. Karlsen, Limas Kupčinskas, Subra Kugathasan, Anna Latiano, Debby Laukens, Ian C. Lawrance, Charlie W. Lees, Édouard Louis, Gillian Mahy, John Mansfield, Angharad R. Morgan, Craig Mowat, William G. Newman, Orazio Palmieri, Cyriel Y. Ponsioen, Uroš Potočnik, Natalie J. Prescott, Miguel Regueiro, Jerome I. Rotter, Richard K. Russell, Jeremy Sanderson, Miquel Sans, Jack Satsangi, Stefan Schreiber, Lisa A. Simms, Jurgita Šventoraitytė, Stephan R. Targan, Kent D. Taylor, Mark Tremelling, Hein W. Verspaget, Martine De Vos, Cisca Wijmenga, David C. Wilson, Juliane Winkelmann, Ramnik J. Xavier, Sebastian Zeißig, Bin Zhang, Hu Zhang, Hongyu Zhao, Mark S. Silverberg, Vito Annese, Håkon Håkonarson, Steven R. Brant, Graham Radford‐Smith, Christopher G. Mathew, John D. Rioux, Eric E. Schadt ほか 6 名 - Nature 2012 被引用: 4,917

  3. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,727

  4. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases

    著者: , , , , , , , , , , , , , , , , , - Gastroenterology 2017 被引用: 586

  5. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet 2023 被引用: 333

  6. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Ferrante - The Lancet 2022 被引用: 387

  7. Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

    著者: , , , , , , , , , , , , , , , , , , , , - Canadian Journal of Gastroenterology 2005 被引用: 3,392

  8. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 437

  9. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 被引用: 912

  10. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geert D’Haens - The Lancet 2022 被引用: 316

  11. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    著者: , , , , , , , , , , - The Lancet 2002 被引用: 4,163

  12. Transcriptome and genome sequencing uncovers functional variation in humans

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helena Kilpinen, Sergi Beltrán, Marta Gut, Katja Kahlem, Vyacheslav Amstislavskiy, Oliver Stegle, Matti Pirinen, Stephen B. Montgomery, Peter Donnelly, Mark I. McCarthy, Paul Flicek, Tim M. Strom, Hans Lehrach, Stefan Schreiber, Ralf Sudbrak, Ángel Carracedo, Stylianos E. Antonarakis, Robert Häsler, Ann‐Christine Syvänen, Gert‐Jan B. van Ommen, Alvis Brāzma, Thomas Meitinger, Philip Rosenstiel, Roderic Guigó, Marta Gut, Xavier Estivill, Emmanouil T. Dermitzakis - Nature 2013 被引用: 2,195

  13. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection

    著者: , , , , , , , , , , , - Gastroenterology 2016 被引用: 710

  14. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cisca Wijmenga, Robert N. Baldassano, Murray L. Barclay, Theodore M. Bayless, Stephan Brand, Carsten Büning, Albert Cohen, J F. Colombel, Mario Cottone, Laura Stronati, Ted Denson, Martine De Vos, R. D’Incà, Marla C. Dubinsky, Cathryn Edwards, Tim Florin, Denis Franchimont, Richard B. Gearry, Jürgen Glas, A. Van Gossum, Stephen L. Guthery, Jonas Halfvarson, Hein W. Verspaget, Jean‐Pierre Hugot, Amir Karban, Debby Laukens, Ian C. Lawrance, Marc Lémann, Arie Levine, Cécile Libioulle, Édouard Louis, Craig Mowat, William G. Newman, Julián Panés, Anne Phillips, Deborah D. Proctor, Miguel Regueiro, Richard K. Russell, Paul Rutgeerts, Jeremy Sanderson, Miquel Sans, Frank Seibold, A. Hillary Steinhart, Pieter Stokkers, Leif Törkvist, Gerd A. Kullak‐Ublick, David C. Wilson, Thomas D. Walters, Stephan R. Targan, Steven R. Brant, John D. Rioux, Mauro D’Amato, Rinse K. Weersma, Subra Kugathasan, Anne M. Griffiths, John Mansfield, Séverine Vermeire, Richard H. Duerr, Mark S. Silverberg, Jack Satsangi, Stefan Schreiber, Judy H. Cho, Vito Annese, Håkon Håkonarson, Mark J. Daly, Miles Parkes - Nature Genetics 2010 被引用: 2,581

  15. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 725

  16. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

    著者: , , , , , , , , , , , , , , , , , , , , - Nature 2012 被引用: 1,284

  17. openalex_id:w2145813488

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monika Stoll, Klaus Berger, Nicola Martinelli, Domenico Girelli, Pascal McKeown, Christopher Patterson, Stephen E. Epstein, Joseph M. Devaney, Mary-Susan Burnett, Vincent Mooser, Samuli Ripatti, Ida Surakka, Markku S. Nieminen, Juha Sinisalo, Marja‐Liisa Lokki, Markus Perola, Aki S. Havulinna, Ulf dé Fairé, Bruna Gigante, Erik Ingelsson, Tanja Zeller, Philipp S. Wild, Paul I. W. de Bakker, Olaf H. Klungel, Anke H. Maitland‐van der Zee, Bas Peters, Anthonius de Boer, Diederick E. Grobbee, Pieter W. Kamphuisen, Vera H.M. Deneer, Clara C. Elbers, N. Charlotte Onland‐Moret, Marten H. Hofker, Cisca Wijmenga, W. M. Monique Verschuren, Jolanda M.A. Boer, Yvonne T. van der Schouw, Asif Rasheed, Philippe Frossard, Serkalem Demissie, Cristen J. Willer, Ron Do, José M. Ordovás, Gonçalo R. Abecasis, Michael Boehnke, Karen L. Mohlke, Mark J. Daly, Candace Guiducci, Noël P. Burtt, Aarti Surti, Elena González, Shaun Purcell, Stacey Gabriel, Jaume Marrugat, John F. Peden, Jeanette Erdmann, Patrick Diemert, Christina Willenborg, Inke R. König, Marcus Fischer, Christian Hengstenberg, Andreas Ziegler, Ian Buysschaert, Diether Lambrechts, Frans Van de Werf, Keith A.A. Fox, Nour Eddine El Mokhtari, Deborah C. Rubin, Jürgen Schrezenmeir, Stefan Schreiber ほか 26 名 被引用: 2,293

  18. Genome-wide association study reveals genetic risk underlying Parkinson's disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katrina Gwinn, Marcel van der Brug, Grisel Lopez, Stephen J. Chanock, Arthur Schatzkin, Yikyung Park, Albert R. Hollenbeck, Jianjun Gao, Xuemei Huang, Nick W Wood, Delia Lorenz, Günther Deuschl, Honglei Chen, Olaf Rieß, John Hardy, Andrew Singleton, Thomas Gasser - Nature Genetics 2009 被引用: 1,954

  19. XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease

    著者: , , , , , , , , , , - Cell 2008 被引用: 1,402

  20. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    著者: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2020 被引用: 317

  21. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2021 被引用: 250

  22. Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

    著者: , , , , , , , , , , , , , , , , , - Gastroenterology 2021 被引用: 227

  23. Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

    著者: , , , , , , , , , , - Gastroenterology 2006 被引用: 2,250

  24. Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 1,128